Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

443.10

+18.87 (4.45%)

At close: Sep 29, 2025, 4:00 PM EDT

444.00

+0.90 (0.20%)

After-hours: Sep 29, 2025, 5:55 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2006 - 2008
Period Ending	Dec '24 Dec 31, 2024	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	2006 - 2008
Novel Therapeutics	180.13M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	122439.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2006 - 2008
Period Ending	Dec '24 Dec 31, 2024	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	2006 - 2008
United States	180.13M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	122439.46%	Log In	Log In	Log In	Log In	Upgrade